Table 1.

Summary of the age distribution of 4vhpv vaccine recipients, October 2009 to December 2016.

Age at First Gardasil Dose (Years)	Regimen Initiator Cohorta			Regimen Completer Cohortb
	Dose 1	Dose 2	Dose 3	(3 Doses per Protocol)
	(N = 114,035)	(N = 58,552)	(N = 30,150)	(N = 20,693)
9	454	254	128	87
10	1,019	551	298	180
11	14,591	7,908	4,001	2,759
12	14,445	7,352	3,717	2,529
13	13,275	7,027	3,730	2,473
14	14,156	7,735	4,098	2,684
15	12,633	6,931	3,809	2,521
16	12,195	6,453	3,398	2,291
17	11,324	5,774	2,965	2,243
18	8,310	3,728	1,761	1,320
19	3,061	1,263	591	422
20	1,980	785	395	303
21	1,262	537	245	184
22	953	413	188	138
23	857	421	207	172
24	815	415	197	163
25	832	371	147	117
26	622	288	130	107
<9	202	22	10	0
>26	1,049	324	135	0
Total	114,035	58,552	30,150	20,693

^aRegimen Initiators include males any age with at least one dose of 4vHPV vaccine

^bRegimen Completers include males 9-26 years old, completing the 3 dose regimen of 4vHPV vaccine within 12 months with at least (per recommendations) 28 days between doses 1 and 2, 12 weeks between doses 2 and 3, and 24 weeks between doses 1 and 3.